Researchers built an in-cell ELISA that measures the DNA damage marker γH2AX in stable, non-proliferating human hepatocytes ...

Mutations found in about 20% of human cancers may promote malignant growth through a shared change in how DNA is organized, ...

Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer diagnosis ...

Researchers report that the adipogenesis-related gene CEBPD is downregulated in breast tumors, serves as an independent ...

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein ...

A Weissman Lab team combined heritable DNA barcodes with gene expression and spatial data to reconstruct the family trees of ...

A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a particular regulatory protein, according to a study by Weill Cornell Medicine ...